Navistar, Inc.
Summary
NHTSA campaign 22V909: Navistar, Inc. recalled for a safety defect. A rear axle that moves side to side can cause a loss of handling and control, increasing the risk of a crash. In additi
Details
Source
nhtsa
External ID
22V909
Action Date
2022-12-09
Status
Ongoing
Category
vehicle
Product Description
Navistar, Inc. (Navistar) is recalling certain 2023 IC RE, IC EV, and 2023-2024 IC CE school buses. The fasteners that connect the transverse torque arm to the rear axle housing may have been tightened incorrectly, which can allow the rear axle to shift side to side.
Company
Context & Analysis
Navistar, Inc. has 58 FDA actions in our database.
Frequently Asked Questions
How often does Navistar, Inc. have FDA actions?
Navistar, Inc. has 58 FDA actions in our database, including 0 recalls and 0 device clearances.
Where can I find the official FDA record?
The official record is available on FDA.gov. Use the link above to view the complete official filing. You can also use the openFDA API to query this record programmatically.
Want to know the moment something like this happens?
Get alerts for vehicle